{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:32:57Z","timestamp":1773509577624,"version":"3.50.1"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2005,1,18]],"date-time":"2005-01-18T00:00:00Z","timestamp":1106006400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2005,2]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Endothelins and nitric oxide regulate sinusoidal blood flow and the perfusion of the peribiliary vascular plexus.<\/jats:p><jats:p><jats:bold>Aims<\/jats:bold> :\u2002To study the serum and hepatic vein concentration of ET\u20101, ET\u20102, ET\u20103 and nitric oxide in patients with primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Endothelins and nitrites\/nitrates were measured in serum and hepatic vein blood in primary biliary cirrhosis and viral cirrhotic patients prior and after ursodeoxycholic acid therapy and in serum in controls. Endothelins were measured with commercial enzyme\u2010linked immunosorbent assays and nitrites\/nitrates with a modification of Griess reaction.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002The ET\u20101 and ET\u20103 levels were similar in patients and controls. Primary biliary cirrhosis patients had the highest serum ET\u20102 (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.001) compared with other groups. Nitrites\/nitrates was increased in primary biliary cirrhosis (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) compared with normal. ET\u20102 and nitric oxide were similar in all primary biliary cirrhosis stages. Ursodeoxycholic acid significantly decreased ET\u20102 in all stages (I and II: <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05 and III and IV: <jats:italic>P<\/jats:italic>\u2003&lt;\u20030.01) and increased nitric oxide (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) in early primary biliary cirrhosis. Hepatic vein ET\u20101 and ET\u20103 were higher in viral cirrhosis patients, but only in primary biliary cirrhosis a significant difference for ET\u20101 and ET\u20103 between hepatic and peripheral veins was found.<\/jats:p><jats:p><jats:bold>Conclusions<\/jats:bold> :\u2002Increased ET\u20102 is an early defect in primary biliary cirrhosis that is significantly reduced by the ursodeoxycholic acid treatment. The possibility of a more generalized endothelial cell dysfunction in primary biliary cirrhosis requires further investigation.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2005.02307.x","type":"journal-article","created":{"date-parts":[[2005,2,4]],"date-time":"2005-02-04T09:27:25Z","timestamp":1107509245000},"page":"227-234","source":"Crossref","is-referenced-by-count":10,"title":["Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis"],"prefix":"10.1111","volume":"21","author":[{"given":"P.","family":"Dimoulios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kolios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Notas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Matrella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Xidakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Koulentaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Kouroumalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,1,18]]},"reference":[{"key":"e_1_2_16_2_2","first-page":"325","article-title":"Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology","volume":"46","author":"Rubanyi GM","year":"1994","journal-title":"Pharmacol Rev"},{"key":"e_1_2_16_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(12)80920-6"},{"key":"e_1_2_16_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0196-9781(93)90057-N"},{"key":"e_1_2_16_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.1999.03176.x"},{"key":"e_1_2_16_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.2.189"},{"key":"e_1_2_16_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64807-9"},{"key":"e_1_2_16_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(94)90018-3"},{"key":"e_1_2_16_9_2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.8.895"},{"key":"e_1_2_16_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50044"},{"key":"e_1_2_16_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.172.6.1741"},{"key":"e_1_2_16_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510230655"},{"key":"e_1_2_16_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292706"},{"key":"e_1_2_16_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.6711"},{"key":"e_1_2_16_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)49528-8"},{"key":"e_1_2_16_16_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2002.31432"},{"key":"e_1_2_16_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(02)00266-0"},{"key":"e_1_2_16_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1746.2002.02689.x"},{"key":"e_1_2_16_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1998.00696.x"},{"key":"e_1_2_16_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03470.x"},{"key":"e_1_2_16_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1281928"},{"key":"e_1_2_16_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00432479"},{"key":"e_1_2_16_23_2","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.24.1219"},{"key":"e_1_2_16_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2001.00269.x"},{"key":"e_1_2_16_25_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007129"},{"key":"e_1_2_16_26_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1996.v110.pm8566602"},{"key":"e_1_2_16_27_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1007127"},{"key":"e_1_2_16_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212173272502"},{"key":"e_1_2_16_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(92)90519-U"},{"key":"e_1_2_16_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90360-O"},{"key":"e_1_2_16_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840210321"},{"key":"e_1_2_16_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160117"},{"key":"e_1_2_16_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80100-6"},{"key":"e_1_2_16_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02806347"},{"key":"e_1_2_16_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(96)80025-0"},{"key":"e_1_2_16_36_2","first-page":"A61","article-title":"Circulating endothelin\u20101 and nitric oxide in primary biliary cirrhosis","volume":"44","author":"Notas G","year":"1999","journal-title":"Gut"},{"key":"e_1_2_16_37_2","doi-asserted-by":"publisher","DOI":"10.1159\/000178953"},{"key":"e_1_2_16_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840110503"},{"key":"e_1_2_16_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00940.x"},{"key":"e_1_2_16_40_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-35413"},{"key":"e_1_2_16_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(01)00168-4"},{"key":"e_1_2_16_42_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.20240"},{"key":"e_1_2_16_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(00)80216-0"},{"key":"e_1_2_16_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290301"},{"key":"e_1_2_16_45_2","doi-asserted-by":"publisher","DOI":"10.1053\/bega.2000.0107"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2005.02307.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2005.02307.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T20:49:50Z","timestamp":1697230190000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2005.02307.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,18]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["10.1111\/j.1365-2036.2005.02307.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02307.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,18]]}}}